The SURMOUNT-3 and SURMOUNT-4 studies answer the crucial question: what happens long-term with tirzepatide? One of the main challenges of anti-obesity treatments is long-term weight loss maintenance. The SURMOUNT-3 and SURMOUNT-4 studies, published in 2023 and 2024, provide essential data on the durability … Read more
The SURMOUNT-2 study demonstrates that tirzepatide is equally effective in patients combining type 2 diabetes and obesity, with major glycemic benefits. Following the spectacular results of SURMOUNT-1 in non-diabetic patients, the question arose: would tirzepatide be as effective in patients simultaneously presenting with type 2 diabetes … Read more
The SURMOUNT-1 study laid the scientific foundation for the use of tirzepatide in obesity. A detailed analysis of the game-changing results. Published in the New England Journal of Medicine in July 2022, the SURMOUNT-1 study is the pivotal clinical trial that led to the authorization of tirzepatide (Zepbound) for the treatment of obesity. With 2,539 participants … Read more
Survodutide, retatrutide, orforglipron: molecules that could surpass Mounjaro are already in advanced clinical trials. While tirzepatide (Mounjaro/Zepbound) has revolutionized obesity treatment with its dual GIP/GLP-1 action, pharmaceutical research doesn’t stop. Several new-generation molecules are under development, promising even more impressive results. An overview of treatments that could redefine obesity management in the coming years. Read more
Tirzepatide does more than just reduce appetite: it simultaneously acts on three vital organs to combat obesity and type 2 diabetes. Tirzepatide, the active ingredient in Mounjaro and Zepbound, is often presented as a simple injectable appetite suppressant. This reductive view ignores the complexity of its mechanism of action. In reality, this … Read more
Progressive tirzepatide titration (2.5 to 15 mg) is essential to minimize nausea and maximize efficacy. Complete schedule for all GLP-1 users.
Discover how to effectively track your Mounjaro treatment. Injection log, weight tracking, side effects: our complete 2026 guide to optimize your tirzepatide treatment with MounjaGO.
Which GLP-1 tracking app to choose in 2026? A complete comparison between MounjaGO and other apps: injection reminders, weight tracking, medical PDF reports. Find the right tool for your Mounjaro treatment.
Why is the number on the scale not enough while on Mounjaro? Discover the key indicators to monitor: body composition, energy, side effects, and overall well-being for comprehensive tracking.
Anti-obesity treatments like Mounjaro or Wegovy are not miracles. But when used with rigorous support, they can save lives. Discover the golden rules to maximize the results of your GLP-1 treatment.